Diploid

Foundation date

2015

Sector

#Biotechnology / R&D Services

Subsector

Diploid offers human genome interpretation as a service to genetic departments, commercial labs and the pharmaceutical industry. Interpretation is focused on rare disease diagnostics, preventative cancer screening and pharmacogenomics.

Upcoming events

Latest news

  • SeptiCyte® RAPID receives 510(k) clearance by US FDA

    1 day ago

  • QbD and Inovigate launch Health to Market, a contract commercialization organization in life sciences

    1 day ago

  • Dimitrios Mantzilas joins Precirix as Chief Technology Officer

    1 day ago